Skip to main content
Tech.euFundingExplorerBeta

Generare

a biotech uncovering the next generation of medicines and high-value molecules hiding in soil bacteria

Generare has raised €25M across 2 funding rounds from 11 investors, most recently a Series A round in Apr 2026. Based in Paris, France; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€25M
€25,000,000
Funding rounds
2
Investors
11
distinct backers
Active since
2024-10
latest 2026-04

Funding by year

EUR raised per year · 2026 YTD
Generare — funding by year — interactive chart.
Data table
Generare — funding by year
2024€5.0M
2026€20M

Signals

High confidence
Raise-next likelihood40
base rate 44% for Series A
  • ▼ Raised very recently
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood17
base rate 11% (2+ rounds)
  • ▼ Young (<3y)
  • ▲ Recently backed by strong-exit-track investors

Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

2 rounds
DateStageAmountInvestors
2026-04-02Series A€20MAlven Capital,Daphni,Existing investors,Galion.exe,TeamPact Ventures,VIVES PartnersView deal →
2024-10-08Seed€5.0MBetter Angle,Business Angels,Galion.exe,Saras Capital,Synbioven,TeamPact Ventures+1 moreView deal →

Related news

Similar companies

same sector or country

Global coverage: FundingData